A Two-Part Intervention to Target Cardiovascular Health
Autism Research Consortium on Physical Health: A Two-Part Intervention to Target Cardiovascular Health
Obesity is one of the most common health conditions among autistic young people and its prevalence rises at faster rates for autistic-relative to non-autistic-individuals. This places them at heightened risk for cardiovascular disease (CVD) and mortality before they enter adulthood. Studies have identified three key contributing factors to CVD outcomes in autistic individuals: unhealthy lifestyle behaviors, Adverse Childhood Experiences (ACEs), and chronic stress.
This study will explore the effectiveness of two CVD-focused primary care interventions for autistic individuals (ages 9-26): (1) lifestyle medicine consultations tailored towards supporting health-promoting behaviors; and (2) a Cognitive Behavioral Therapy (CBT) intervention tailored towards addressing chronic stress that contributes to excess weight and maladaptive eating behaviors and results in obesity and CVD. Participants and their caregivers will be randomly placed into either the Lifestyle Medicine Group, CBT Group, or combined Lifestyle Medicine with CBT Group. Participants will respond to questionnaires and surveys measuring lifestyle habits, stress, and psychological risk factors at their first visit, 6-month visit, and 3 months post-intervention visit. Over the course of 6 months, participants will attend virtual sessions (up to three times a month) in accordance with their intervention group.
Tutkimuksen yleiskatsaus
Tila
Yksityiskohtainen kuvaus
Autistic individuals experience almost three times the mortality rate relative to non-autistic populations, and are disproportionately likely to experience obesity-with increasing rates beginning in childhood and adolescence-relative to both the general population and those with other developmental conditions. Obesity is one of the most common health conditions among autistic young people and its prevalence rises at faster rates for autistic-relative to non-autistic-individuals. This places them at heightened risk for cardiovascular disease (CVD) and mortality before they enter adulthood.
Studies have identified three key contributing factors to CVD outcomes in autistic individuals: unhealthy lifestyle behaviors, Adverse Childhood Experiences (ACEs), and chronic stress. Taken together, this study addresses a critical gap in the field: lack of appropriate and effective healthcare/lifestyle interventions for autistic individuals with CVD and/or experiences of chronic stress that lead to obesity and poor cardiovascular health. These efforts require dedicated interventions selected for their impact on two key mechanisms underlying obesity and CVD: lifestyle and ACEs/chronic stress.
This study will explore the effectiveness of two CVD-focused primary care interventions for autistic individuals (ages 9-26): (1) lifestyle medicine consultations tailored towards supporting health-promoting behaviors; and (2) a Cognitive Behavioral Therapy (CBT) intervention tailored towards addressing chronic stress that contributes to excess weight and maladaptive eating behaviors and results in obesity and CVD. Participants and their caregivers will be randomly placed into either the Lifestyle Medicine Group, CBT Group, or combined Lifestyle Medicine with CBT Group. Participants will respond to questionnaires and surveys measuring lifestyle habits, stress, and psychological risk factors at their first visit, 6-month visit, and 3 months post-intervention visit. Over the course of 6 months, participants will attend virtual sessions (up to three times a month) in accordance with their intervention group.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
California
-
Los Angeles, California, Yhdysvallat, 90024
- 1100 Glendon Ave
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Lapsi
- Aikuinen
Hyväksyy terveitä vapaaehtoisia
Kuvaus
Inclusion Criteria:
• Have a diagnosis of autism or be told by a healthcare provider that you have autism
- Be between the ages of 9 and 26
- Have a BMI greater than the 84th percentile
- English speaking
Exclusion Criteria:
• Children younger than 9 years of age
- Adults older than 26 years of age
- Individuals without a diagnosis of autism
- Individuals with a BMI less than the 84th percentile
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Tukevaa hoitoa
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Active Comparator: 1) Lifestyle Medicine Group
This group will receive the Lifestyle Medicine Intervention.
This intervention is comprised of 6 monthly lifestyle medicine consultations with a health coach.
|
The intervention is a series of lifestyle medicine consultations.
|
|
Active Comparator: Cognitive Behavioral Therapy (CBT) Group
This group will receive the CBT Intervention.
This intervention is comprised of 12, twice-monthly CBT sessions over the span of 6 months.
|
The intervention is a series of CBT sessions.
|
|
Active Comparator: Lifestyle Medicine with CBT Group
This group will receive both the Lifestyle Medicine and CBT Interventions.
|
Receives both Lifestyle Medicine and CBT interventions
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Behavior Assessment System for Children: Third Edition (BASC-3)
Aikaikkuna: Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
A series of instruments designed to help aid in the diagnosis and treatment of children, adolescents, and young adults between the ages of 2 and 25 - captures self- and/or caregiver reported psychological distress.
|
Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
|
American College of Lifestyle Medicine (ACLM) Nutrition in Action Diet Screener
Aikaikkuna: Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
Self- and/or caregiver reported diet, physical activity, sleep, stress, and motivation to change.
|
Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
|
Adverse Childhood Experiences Screener (PEARLS/ACEs)
Aikaikkuna: Administered at Baseline
|
Captures adverse childhood experiences.
|
Administered at Baseline
|
|
General Nutrition Knowledge Questionnaire (GNKQ)
Aikaikkuna: Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
Captures general knowledge of nutrition and food groups.
|
Administered at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
|
Project EAT-IV Survey
Aikaikkuna: Administered at Baseline
|
Self- and/or caregiver reported diet, physical activity, sleep, and stress.
|
Administered at Baseline
|
|
Participant and Caregiver Survey
Aikaikkuna: Administered at final intervention visit (6-month mark).
|
Addresses participant and caregiver experience in the study - captures acceptability and feasibility of intervention.
|
Administered at final intervention visit (6-month mark).
|
|
Childhood Autism Rating Scale: Second Edition (CARS-2)
Aikaikkuna: Administered at Baseline
|
Identifies autism spectrum disorder (ASD) in children and the severity of their symptoms.
|
Administered at Baseline
|
|
ASD DSM-5 Checklist
Aikaikkuna: Administered at Baseline
|
Captures diagnostic criterion from clinicians when used to diagnose Autism Spectrum Disorder.
|
Administered at Baseline
|
|
Vineland Adaptive Behavioral Scales: Third Edition (Vineland-III)
Aikaikkuna: Administered at Baseline
|
Used to measure adaptive behaviors and aid in the diagnosis of intellectual and developmental disabilities.
|
Administered at Baseline
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Cardiovascular disease (CVD) indicators
Aikaikkuna: Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
Height (cm)
|
Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
|
Cardiovascular disease (CVD) indicators
Aikaikkuna: Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
Weight (kg)
|
Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
|
Cardiovascular disease (CVD) indicators
Aikaikkuna: Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
Waist circumference (cm)
|
Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
|
Cardiovascular disease (CVD) indicators
Aikaikkuna: Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
Blood pressure (mmHg)
|
Collected at Baseline, at final intervention visit (6-month mark), and 3-Months post-intervention.
|
Yhteistyökumppanit ja tutkijat
Yhteistyökumppanit
Tutkijat
- Päätutkija: Alice Kuo, MD, PhD, University of California, Los Angeles
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 25-1848
- 6 UM4MC54990-01-01 (Muu apuraha/rahoitusnumero: HRSA)
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .